vs
Side-by-side financial comparison of Orion S.A. (OEC) and Zentek Ltd. (ZTEK). Click either name above to swap in a different company.
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Zentek Ltd. is a Canada-based nanotechnology innovation company that develops, produces and commercializes graphene-based functional materials and solutions. Its core offerings include antimicrobial coatings, high-efficiency air filtration products and advanced protective materials, serving key segments of healthcare, industrial, defense and consumer goods markets across North America and global regions.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $411.7M | — | ||
| Q3 25 | $450.9M | — | ||
| Q2 25 | $466.4M | — | ||
| Q1 25 | $477.7M | — | ||
| Q4 24 | $434.2M | — | ||
| Q3 24 | $463.4M | — | ||
| Q2 24 | $477.0M | — | ||
| Q1 24 | $502.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-67.1M | — | ||
| Q2 25 | $9.0M | — | ||
| Q1 25 | $9.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-20.2M | — | ||
| Q2 24 | $20.5M | — | ||
| Q1 24 | $26.7M | — |
| Q4 25 | 18.9% | — | ||
| Q3 25 | 19.0% | — | ||
| Q2 25 | 21.1% | — | ||
| Q1 25 | 20.5% | — | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 23.2% | — | ||
| Q2 24 | 23.0% | — | ||
| Q1 24 | 24.3% | — |
| Q4 25 | 4.3% | — | ||
| Q3 25 | -11.9% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 8.7% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | -14.9% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | $-0.36 | — | ||
| Q3 25 | $-1.20 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.16 | — | ||
| Q4 24 | $0.31 | — | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $0.35 | — | ||
| Q1 24 | $0.45 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
